Alumis and Acelyrin finalise amended merger agreement with improved terms
The merger aims to create a major late-stage clinical biopharma company dedicated to developing and commercialising innovative therapies for immune-mediated diseases
UK authorises GSK’s Blenrep combinations for treatment-resistant multiple myeloma
Sanofi, Regeneron’s Dupixent granted FDA approval to treat CSU
Calidi secures FDA IND approval for CLD-201 in solid tumours
Tevogen Bio Finalizes Agreement for Company’s Own Cell Therapy Production Facility
GSK’s Penmenvy gets CDC advisory committee support for adolescent vaccination
Analysis
View More
Risks
View MoreSocietal polarisation and its impact on the pharmaceutical industry
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry